Abstract. In this research, we established a MPTP mouse model of PD, then ultrasound was used to stimulate the model to explore the effects of ultrasound on behavior and dopamine content in striatum. With the prolongation of ultrasonic stimulation time, the delay of observation time, the amount of DA in the striatum of the ultrasonic treatment group was increasing. Using ultrasound with a frequency of 1 MHz at an intensity of 0.3W/cm 2 over 15min for 1d, 5d or 10d respectively, in each group, there was a significant difference in the content of DA in the striatum compare to PD observation group at the same observation time(P<0.05). Especially, the DA content in the striatum of the mice treated with the ultrasound for 10 d was not statistically significant compared with the control group(P>0.05). Combined with the results of climbing test and open field test and general behavioral changes, the difference between ultrasound group and PD group reached a significant level (P<0.05). In summary, ultrasound can increase the DA content in the brain and improve the motor capacity of PD model. It suggests that ultrasound may be a safe and effective new method of PD treatment.
IntroductionParkinson's disease (PD) is a common neurodegenerative disorder characterized by the reduce of the striatal DA level, which is related to the degeneration, death and deletion of dopaminergic neurons in the substantia nigra pars compacta (SNc), as well as the decrease of dopamine biosynthesis ability of the surviving neurons [1][2][3]. A series of clinical symptoms including resting tremor, rigidity, bradykinesia and postural instability will appear when DA content is lower than 70%. The gold standard for the treatment of PD is Levodopa therapy, which is aimed at increasing the availability of striatal dopamine and typically result in a brisk symptomatic improvement in most PD patients. Unfortunately, this response becomes less reliable and less predictable over time, medication related complications such as dyskinesia and "on-off" fluctuations develop in a majority of patients [4]. Because of the side effect of Levodopa therapy, researchers started to explore new therapies for PD.Ultrasound, as a new physical therapy, has been shown to be an effective neuronal activity regulator. William et al [5] experiments found that ultrasound on the cat's lateral geniculate body can inhibit the visual cortex evoked potential. Bauer et al [6] in the study results confirmed that after the end of ultrasound intervention in patients with tremor ease, six months after treatment and the Webster score was significantly improved. Wang et al found that GDNF levels were increased in the striatum of PD rats after lipid-coated GDNF microspheres administration following low frequency ultrasound stimulation (20kHz, 5min per day, daily for 4weeks). Moreover, GDNF microspheres reduced apomorphine-induced rotations, and increased striatal dopamine and nigral tyrosine hydroxylase (TH) levels in PD rats. In this research, we established a MPTP mouse model of PD, then u...